TradingKey

关于 AtriCure Inc 公司

AtriCure, Inc. 提供治疗心房颤动 (Afib)、左心耳 (LAA) 管理和术后疼痛管理的技术。该公司的心脏消融和左心耳管理 (LAAM) 产品供医生在开胸和微创外科手术中使用。其疼痛管理解决方案供医生在心胸外科或胸外科手术过程中冻结神经。该公司的开放式和微创消融产品包括 Isolator Synergy 夹钳和多功能笔和线性消融设备。其开放式消融产品包括 cryoICE 冷冻消融系统。其微创消融产品包括采用 VisiTrax 技术的 EPi-Sense 引导凝血系统。其附属物管理产品包括 AtriClip 系统。Isolator Synergy 消融系统夹钳是一次性使用的射频 (RF) 产品，其钳口以平行方式闭合。

公司简介

公司代码ATRC

公司名称AtriCure Inc

上市日期Aug 05, 2005

CEOMr. Michael H. (Mike) Carrel, CPA

员工数量1300

证券类型Ordinary Share

年结日Aug 05

公司地址7555 Innovation Way

城市MASON

上市交易所NASDAQ Global Market Consolidated

国家United States of America

邮编45040

电话15137554100

网址https://www.atricure.com

公司代码ATRC

上市日期Aug 05, 2005

CEOMr. Michael H. (Mike) Carrel, CPA

公司高管

名称

名称/职务

职务

持股

持股变动

Mr. Michael H. (Mike) Carrel, CPA

President, Chief Executive Officer, Director

718.94K

+0.11%

Mr. Salvatore Privitera, J.D.

Chief Technical Officer

125.59K

+0.66%

Mr. Robert S. (Bob) White

Independent Chairman of the Board

92.17K

+20.06%

Mr. Justin J. Noznesky

Chief Marketing and Strategy Officer

86.96K

+23.01%

Dr. Vinayak Doraiswamy, Ph.D.

Chief Scientific Officer

74.37K

+1.12%

Mr. Karl S. Dahlquist, J.D.

Chief Legal Officer

68.55K

+1.21%

Ms. Regina E. (Reggie) Groves

Independent Director

36.17K

+17.56%

Mr. Sven A. Wehrwein, CPA

Independent Director

34.37K

+18.64%

Ms. Deborah H. (Deb) Telman

Independent Director

22.18K

+32.18%

Mr. Shlomo Nachman

Independent Director

18.51K

+41.20%

名称

名称/职务

职务

持股

持股变动

Mr. Michael H. (Mike) Carrel, CPA

President, Chief Executive Officer, Director

718.94K

+0.11%

Mr. Salvatore Privitera, J.D.

Chief Technical Officer

125.59K

+0.66%

Mr. Robert S. (Bob) White

Independent Chairman of the Board

92.17K

+20.06%

Mr. Justin J. Noznesky

Chief Marketing and Strategy Officer

86.96K

+23.01%

Dr. Vinayak Doraiswamy, Ph.D.

Chief Scientific Officer

74.37K

+1.12%

Mr. Karl S. Dahlquist, J.D.

Chief Legal Officer

68.55K

+1.21%

收入明细

单位: USD更新时间: 7月6日周日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Appendage Management-United states

42.09M

34.05%

Open Ablation - United states

33.31M

26.94%

Pain management

17.27M

13.97%

Appendage management -International

9.67M

7.83%

Open ablation -International

8.99M

7.28%

Other

12.28M

9.94%

地区USD

名称

营收

占比

United States

101.15M

81.82%

Europe

14.20M

11.49%

Asia

6.78M

5.49%

Other international

1.49M

1.20%

业务

地区

业务USD

名称

营收

占比

Appendage Management-United states

42.09M

34.05%

Open Ablation - United states

33.31M

26.94%

Pain management

17.27M

13.97%

Appendage management -International

9.67M

7.83%

Open ablation -International

8.99M

7.28%

Other

12.28M

9.94%

股东统计

更新时间: 5月20日周二

持股股东

股东类型

持股股东

占比

The Vanguard Group, Inc.

9.46%

AllianceBernstein L.P.

7.40%

BlackRock Institutional Trust Company, N.A.

7.19%

Hood River Capital Management LLC

6.03%

Macquarie Investment Management

4.90%

Other

65.02%

持股股东

占比

The Vanguard Group, Inc.

9.46%

AllianceBernstein L.P.

7.40%

BlackRock Institutional Trust Company, N.A.

7.19%

Hood River Capital Management LLC

6.03%

Macquarie Investment Management

4.90%

Other

65.02%

股东类型

持股股东

占比

Investment Advisor

56.65%

Investment Advisor/Hedge Fund

33.71%

Hedge Fund

10.66%

Individual Investor

3.55%

Research Firm

1.93%

Pension Fund

0.75%

Bank and Trust

0.50%

Sovereign Wealth Fund

0.23%

Family Office

0.07%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

531

53.52M

108.11%

-4.10M

2025Q1

544

53.44M

107.95%

-4.07M

2024Q4

526

50.00M

102.31%

-11.07M

2024Q3

522

53.78M

110.47%

-8.64M

2024Q2

511

54.11M

111.85%

-4.03M

2024Q1

517

53.02M

109.65%

-1.47M

2023Q4

515

50.20M

105.93%

-1.70M

2023Q3

504

48.87M

103.22%

-3.82M

2023Q2

499

48.88M

103.48%

-3.46M

2023Q1

503

48.62M

102.63%

-1.48M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

The Vanguard Group, Inc.

4.70M

9.5%

+61.17K

+1.32%

Mar 31, 2025

AllianceBernstein L.P.

3.68M

7.43%

-158.60K

-4.14%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

3.57M

7.21%

-92.41K

-2.52%

Mar 31, 2025

Hood River Capital Management LLC

3.00M

6.06%

+75.48K

+2.58%

Mar 31, 2025

Macquarie Investment Management

2.44M

4.92%

+61.60K

+2.59%

Mar 31, 2025

Champlain Investment Partners, LLC

2.14M

4.32%

-390.65K

-15.45%

Mar 31, 2025

Two Sigma Investments, LP

1.33M

2.68%

+75.83K

+6.06%

Mar 31, 2025

First Light Asset Management, LLC

1.31M

2.66%

-654.50K

-33.24%

Mar 31, 2025

State Street Global Advisors (US)

1.28M

2.58%

-68.53K

-5.09%

Mar 31, 2025

UBS Asset Management (Switzerland)

1.26M

2.54%

+537.08K

+74.31%

Mar 31, 2025

持股ETF

更新时间: 8月2日周六

机构名称

占比

SPDR S&P Health Care Equipment ETF

1.81%

Harbor Human Capital Factor US Small Cap ETF

0.76%

NYLI Healthy Hearts ETF

0.47%

First Trust Small Cap Growth AlphaDEX Fund

0.45%

Invesco NASDAQ Future Gen 200 ETF

0.43%

Amplify Etho Climate Leadership U.S. ETF

0.3%

JPMorgan Fundamental Data Science Small Core ETF

0.26%

Franklin US Small Cap Multifactor Index ETF

0.25%

First Trust Small Cap Core Alphadex Fund

0.24%

iShares U.S. Medical Devices ETF

0.18%

SPDR S&P Health Care Equipment ETF

占比1.81%

Harbor Human Capital Factor US Small Cap ETF

占比0.76%

NYLI Healthy Hearts ETF

占比0.47%

First Trust Small Cap Growth AlphaDEX Fund

占比0.45%

Invesco NASDAQ Future Gen 200 ETF

占比0.43%

Amplify Etho Climate Leadership U.S. ETF

占比0.3%

JPMorgan Fundamental Data Science Small Core ETF

占比0.26%

Franklin US Small Cap Multifactor Index ETF

占比0.25%

First Trust Small Cap Core Alphadex Fund

占比0.24%

iShares U.S. Medical Devices ETF

占比0.18%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

AtriCure Inc

34.508USD

AtriCure Inc

34.508

概览

公司

财务